News

Filter

Current filters:

Herceptin

1 to 9 of 358 results

Roche shares fall sharply on disappointing Ph III MARIANNE study

Roche shares fall sharply on disappointing Ph III MARIANNE study

22-12-2014

Swiss pharma major Roche saw its shares plunge 6.4% to 270.40 Swiss francs on Friday following release…

BiotechnologyGenentechHerceptinKadcylaOncologyPerjetaRoche

Novartis' Afinitor trial does not demonstrate statistical significance in HER2-positive breast cancer

Novartis' Afinitor trial does not demonstrate statistical significance in HER2-positive breast cancer

15-12-2014

Novartis announced that its BOLERO-1 trial of Afinitor (everolimus) in combination with Herceptin (trastuzumab)…

AfinitorHerceptinNovartisNovartis OncologyOncologyPaclitaxelPharmaceuticalResearchSwitzerland

Roche could lose its dominant market share in breast cancer, says IMS report

Roche could lose its dominant market share in breast cancer, says IMS report

03-10-2014

Biosimilars and new generation agents will end the market dominance of established breast cancer drugs,…

AstraZenecaGlobalHerceptinMarkets & MarketingNovartisOncologyPharmaceuticalRochetamoxifen

Report: HER2-positive breast cancer market could treble in USA by 2023

Report: HER2-positive breast cancer market could treble in USA by 2023

02-10-2014

The US treatment market for human epidermal growth factor receptor type 2 (HER2)-positive breast cancer…

HerceptinMarkets & MarketingOncologyPharmaceuticalRocheUSA

Compromised vials of Roche's MabThera found in Germany

Compromised vials of Roche's MabThera found in Germany

15-09-2014

Swiss drug major Roche has said that compromised vials of its arthritis and cancer drug MabThera had…

GermanyHerceptinLegalMabTheraOncologyPharmaceuticalProductionRegulationRoche

Study reveals factors supporting a sustainable European biosimilar medicines market

Study reveals factors supporting a sustainable European biosimilar medicines market

13-06-2014

Biosimilar medicines will deliver an opportunity for increased access to better healthcare for patients…

AvastinBiosimilarsEuropeHealthcareHerceptinHumiraRegulation

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

Benefits of Herceptin outweigh the risk of harm in advanced breast cancer

12-06-2014

In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug trastuzumab,…

HerceptinOncologyPharmaceuticalResearchRochetrastuzumab

1 to 9 of 358 results

Back to top